Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ishikawa

Showing results (261-270 of 404) with videos related to

Pageof 41
Sort By:
Anticancer Research|January 18, 2003
Combined effect of hyperthermia at 42 degrees C and irradiation dose of 2 Gy on two rat yolk sac tumor cell lines with different radio-thermosensitivity in vitroYoshio Tamaki, Norio Mitsuhashi, Hideyuki Sakurai, et al.
Anticancer Research|October 28, 2025
Long-term Outcomes of Carbon-ion Radiotherapy for Inoperable Locally Advanced Olfactory NeuroblastomaHiroaki Ikawa, Makoto Shinoto, Masashi Koto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2014
Dose distribution resulting from changes in aeration of nasal cavity or paranasal sinus cancer in the proton therapyNobuyoshi Fukumitsu, Hitoshi Ishikawa, Kayoko Ohnishi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 15, 2013
Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective studyHiroyuki Katoh, Hiroshi Tsuji, Hitoshi Ishikawa, et al.
Journal of Radiation Research|January 2, 2023
Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancerMasatoshi Nakamura, Hitoshi Ishikawa, Kayoko Ohnishi, et al.
Advances in Radiation Oncology|May 23, 2024
Carbon Ion Radiation Therapy for Nonmetastatic Castration-Resistant Prostate Cancer: A Retrospective AnalysisYuhei Miyasaka, Hidemasa Kawamura, Hiro Sato, et al.
Journal of Radiation Research|January 4, 2017
Five-year quality of life assessment after carbon ion radiotherapy for prostate cancerKatsuya Maruyama, Hiroshi Tsuji, Takuma Nomiya, et al.
Japanese Journal of Clinical Oncology|July 20, 2012
Long-term follow-up of a randomized Phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer (KROSG0101/JROSG021)Yasumasa Nishimura, Masahiro Hiraoka, Ryuta Koike, et al.
International Journal of Cancer|June 2, 2004
Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancerMakoto Sohda, Hitoshi Ishikawa, Norihiro Masuda, et al.
The Prostate|November 3, 2024
Significant Effect of Carbon-Ion Radiation Therapy Combined With Androgen Deprivation on Biochemical Recurrence Rates in High-Risk Prostate Cancer Patients: A Two-Center Controlled Trial Compare With X-Ray External Beam Radiation TherapyXue Zhao, Shinichi Sakamoto, Hitoshi Ishikawa, et al.
Pageof 41

Showing results (261-270 of 404) with videos related to

Sort By:
Pageof 41
Anticancer Research|January 18, 2003
Combined effect of hyperthermia at 42 degrees C and irradiation dose of 2 Gy on two rat yolk sac tumor cell lines with different radio-thermosensitivity in vitroYoshio Tamaki, Norio Mitsuhashi, Hideyuki Sakurai, et al.
Anticancer Research|October 28, 2025
Long-term Outcomes of Carbon-ion Radiotherapy for Inoperable Locally Advanced Olfactory NeuroblastomaHiroaki Ikawa, Makoto Shinoto, Masashi Koto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2014
Dose distribution resulting from changes in aeration of nasal cavity or paranasal sinus cancer in the proton therapyNobuyoshi Fukumitsu, Hitoshi Ishikawa, Kayoko Ohnishi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 15, 2013
Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective studyHiroyuki Katoh, Hiroshi Tsuji, Hitoshi Ishikawa, et al.
Journal of Radiation Research|January 2, 2023
Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancerMasatoshi Nakamura, Hitoshi Ishikawa, Kayoko Ohnishi, et al.
Advances in Radiation Oncology|May 23, 2024
Carbon Ion Radiation Therapy for Nonmetastatic Castration-Resistant Prostate Cancer: A Retrospective AnalysisYuhei Miyasaka, Hidemasa Kawamura, Hiro Sato, et al.
Journal of Radiation Research|January 4, 2017
Five-year quality of life assessment after carbon ion radiotherapy for prostate cancerKatsuya Maruyama, Hiroshi Tsuji, Takuma Nomiya, et al.
Japanese Journal of Clinical Oncology|July 20, 2012
Long-term follow-up of a randomized Phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer (KROSG0101/JROSG021)Yasumasa Nishimura, Masahiro Hiraoka, Ryuta Koike, et al.
International Journal of Cancer|June 2, 2004
Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancerMakoto Sohda, Hitoshi Ishikawa, Norihiro Masuda, et al.
The Prostate|November 3, 2024
Significant Effect of Carbon-Ion Radiation Therapy Combined With Androgen Deprivation on Biochemical Recurrence Rates in High-Risk Prostate Cancer Patients: A Two-Center Controlled Trial Compare With X-Ray External Beam Radiation TherapyXue Zhao, Shinichi Sakamoto, Hitoshi Ishikawa, et al.
Pageof 41